Blood Typing Market Size & Growth Forecast 2026–2035, By Segments (Product & Services, Application, Technique, End Use, Test), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Blood Typing Market size stood at USD 2.32 Billion in 2025 and is predicted to grow at a 10.2% CAGR from 2026 to 2035, crossing USD 6.13 Billion by 2035. The industry revenue for 2026 is calculated at USD 2.54 billion.
Get more details on this report
Request Free Sample ReportBlood Typing Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 45.40% market share in 2025, supported by established transfusion infrastructure, extensive laboratory networks, and consistently high testing volumes across healthcare settings.
- Asia Pacific is projected to grow at an 11.42% CAGR, driven by expanding healthcare access, increasing diagnostic capacity, and broader adoption of blood screening and laboratory modernization initiatives.
Segment Momentum
- Reagents & Consumables held a 68.54% share in 2025 due to continuous test-by-test usage in laboratories and hospitals, creating recurring demand that supports both routine operations and high testing volumes.
- Organ Transplants are the fastest-growing application because precise donor-recipient compatibility requirements increase reliance on accurate blood typing, making it critical for procedural success and improved patient outcomes.
Market Expansion Drivers
- Rising demand for safe transfusions and organ compatibility driving routine blood typing procedures.
- Expansion of automated and AI-driven analyzers improving diagnostic accuracy and lab efficiency.
- Growing transplant and surgical volumes increasing demand for advanced immunohematology testing systems.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent players in the blood typing market include Bio-Rad Laboratories, Inc. (United States), Grifols, S.A. (Spain), Immucor, Inc. (United States), Danaher Corporation (United States), Thermo Fisher Scientific Inc. (United States), Quotient Limited (United Kingdom), BAG Diagnostics GmbH (Germany), DIAGAST SAS (France), Merck KGaA (Germany).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Stronger clinical emphasis on preventing transfusion reactions and improving donor-recipient matching is making blood group identification a routine step in emergency care, chronic disease management, maternity services, and transplant preparation. In the blood typing market, this shifts purchasing toward reliable reagents, consumables, and testing platforms that can support frequent, standardized screening rather than occasional use. Hospitals, blood banks, and diagnostic laboratories are tightening pre-transfusion protocols and compatibility workflows, which is increasing demand for the market through higher testing volumes and more consistent use of confirmatory typing and cross-matching procedures.
Expansion of automated and AI-driven analyzers improving diagnostic accuracy and lab efficiency
Laboratories are under pressure to reduce manual interpretation, limit clerical error, and process larger sample volumes without proportionally increasing staffing, making automated and AI-enabled systems increasingly attractive. In the blood typing market, these platforms influence adoption by improving result consistency, accelerating turnaround times, and integrating testing data into broader laboratory information workflows. This changes procurement behavior in favor of higher-throughput analyzers and compatible reagent ecosystems, while also supporting market expansion among hospital networks and reference labs seeking scalable immunohematology operations with tighter quality control.
Growing transplant and surgical volumes increasing demand for advanced immunohematology testing systems
As transplant procedures and complex surgeries become more frequent, providers need deeper compatibility assessment and faster access to dependable blood matching to manage perioperative risk and support post-procedure care. That dynamic is supporting market development in the blood typing market by increasing reliance on advanced immunohematology systems capable of handling antibody screening, phenotyping, and compatibility testing with greater precision than basic typing alone. Demand increasingly concentrates around institutions managing high-acuity cases, where the clinical and operational cost of mismatch or delay pushes investment toward more sophisticated testing infrastructure.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for safe transfusions and organ compatibility driving routine blood typing procedures | 2.20% | High | North America, Europe | High | Near Term |
| Expansion of automated and AI-driven analyzers improving diagnostic accuracy and lab efficiency | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Growing transplant and surgical volumes increasing demand for advanced immunohematology testing systems | 1.70% | High | North America, Europe | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading blood typing market share in 2025, accounting for 45.40% share, backed by its established transfusion infrastructure, broad hospital and diagnostic laboratory networks, and routine integration of blood grouping and compatibility testing into clinical workflows. Demand remains anchored in the region’s high testing volumes across surgical care, trauma management, chronic disease treatment, and blood donation programs, while well-developed laboratory automation and quality control practices help sustain consistent product utilization across reagents, instruments, and consumables.
Asia Pacific is projected to expand at an 11.42% CAGR over the forecast period, with growth in the blood typing market being propelled by rising healthcare access, expanding diagnostic capacity, and increasing blood screening activity across densely populated countries. Adoption is accelerating as hospitals and laboratories add testing capabilities to support growing procedural volumes, stronger maternal care and emergency care services, and broader blood bank modernization efforts, creating more frequent and wider use of typing and cross-matching systems in everyday clinical practice.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Laboratory Automation IntegrationGermany emphasizes blood typing technologies that support standardized laboratory processes and high diagnostic precision. Hospitals and blood centers in Germany are integrating automated platforms and digital workflows to improve testing consistency and transfusion safety management.
France 🇫🇷
Public Blood Service SupportFrance maintains a strong focus on blood typing solutions that support organized blood collection and transfusion programs. Healthcare institutions in France are investing in reliable testing technologies that enhance traceability and reinforce national blood safety standards.
Italy 🇮🇹
Hospital Testing ModernizationItaly is gradually modernizing hospital laboratory infrastructure to improve blood typing and transfusion workflows. Healthcare facilities in Italy are seeking automated and user-friendly systems that enhance testing efficiency while supporting consistent patient safety practices.
Japan 🇯🇵
Aging Population Screening DemandJapan's blood typing market benefits from sustained demand for diagnostic testing associated with an aging population and complex healthcare needs. Medical institutions in Japan are prioritizing efficient blood grouping technologies that support routine screening and transfusion preparedness.
South Korea 🇰🇷
Advanced Diagnostic AdoptionSouth Korea is expanding the use of automated blood typing systems within modernized laboratory networks. Healthcare providers in South Korea are emphasizing rapid and accurate testing capabilities to support growing demand for precision diagnostics and efficient blood management practices.
United States 🇺🇸
Transfusion Safety InnovationThe U.S. blood typing market is driven by demand for accurate transfusion management and advanced diagnostic workflows. Healthcare providers in the U.S. are increasing the adoption of automated blood typing systems that improve laboratory efficiency and reduce the risk of incompatibility errors.
Segment Leadership and Growth Trends
Blood Typing Market Share (%), Product & Services, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportReagents & Consumables held a 68.54% share of the blood typing market in 2025, reflecting their central role in routine blood grouping and compatibility workflows across laboratories, hospitals, and blood banks. This segment leads because blood typing depends on repeated, test-by-test use of antisera, assay kits, stains, and other consumable inputs that require continuous replenishment, unlike instruments that are purchased less frequently. The same usage pattern also supports its faster growth in the blood typing market, as rising testing volumes directly translate into recurring demand for these products, particularly where laboratories prioritize dependable throughput, standardized results, and uninterrupted testing operations.
Application Segment Analysis: Diagnostic Testing (Largest Segment) vs Organ Transplants (Fastest-Growing Segment)
Diagnostic Testing accounted for a 56.91% share of the blood typing market in 2025, making it the leading application segment due to its broad and routine use across clinical settings. its position is maintained through the steady need for blood group identification in general diagnostics, pre-procedure screening, and hospital-based patient management, where testing volumes are consistently higher than in more specialized applications. Because these workflows are embedded in day-to-day healthcare delivery, Diagnostic Testing maintains the largest share of the blood typing market through regular, repeat demand.
Organ Transplants are emerging as the fastest-growing application in the blood typing market because transplant procedures require precise donor-recipient compatibility assessment, making blood typing a critical operational step. Growth in this segment is being underpinned by the increasing procedural complexity and higher clinical importance of accurate matching relative to less specialized applications. Compared with routine diagnostic use, transplant-related testing gains momentum from the stricter compatibility requirements tied directly to procedure success and patient outcomes, which increases reliance on dependable blood typing protocols.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product & Services | Instruments, Reagents & Consumables, Services | Reagents & Consumables | Reagents & Consumables |
| Application | Blood Transfusions, Organ Transplants, Diagnostic Testing | Diagnostic Testing | Organ Transplants |
| Technique | PCR Based and Microarray Based, Assay Based Techniques, Massively Parallel Sequencing, Other | PCR Based and Microarray Based | Assay Based Techniques |
| End Use | Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, Others | Diagnostic Laboratories | Blood Banks |
| Test | Antibody Screening, HLA Typing, Cross-matching, ABO Blood Tests, Others | Antibody Screening | HLA Typing |
Competitive Landscape and Market Positioning
1. Bio-Rad Laboratories Inc. (United States)
2. Grifols S.A. (Spain)
3. Immucor Inc. (United States)
4. Danaher Corporation (United States)
5. Thermo Fisher Scientific Inc. (United States)
6. Quotient Limited (United Kingdom)
7. BAG Diagnostics GmbH (Germany)
8. DIAGAST SAS (France)
9. Merck KGaA (Germany)
Diagnostic accuracy improvements are shaping innovation in the blood typing market, particularly through advanced testing methodologies. Automation in laboratory workflows is enhancing speed and reliability of results. Increasing focus on precision diagnostics is strengthening adoption in clinical environments.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Thermo Fisher | May-26 | Thermo Fisher launched the Axiom BloodGenomiX Array and accompanying software designed to enhance blood transfusion safety through genomic-based blood typing and compatibility analysis. The solution enables clinical laboratories to detect extended and rare blood groups, as well as HLA and platelet types, within a high-throughput workflow, improving precision in donor-recipient matching and reducing transfusion-related clinical risks. |
| Bio-Rad Laboratories | Jun-25 | Bio-Rad Laboratories completed the acquisition of Stilla Technologies to expand its digital PCR capabilities supporting precision diagnostics in transfusion medicine. The acquisition strengthens Bio-Rad’s molecular testing portfolio and enhances its ability to deliver advanced blood typing and compatibility solutions, reinforcing its position in high-precision laboratory diagnostics and expanding its technological footprint in genomic applications. |
| Werfen | Mar-25 | Werfen consolidated its transfusion diagnostics portfolio by unifying Immucor and related subsidiaries under a single brand structure. This organizational integration aims to streamline operations across more than 30 countries, improve commercial efficiency, and strengthen its competitive positioning in specialized diagnostics, particularly within immunohematology and transfusion medicine workflows. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Blood Typing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Blood Typing Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much revenue does the blood typing market generate?
How is the blood typing industry size expected to evolve during the forecast period?
How is increasing emphasis on transfusion safety driving routine adoption in the blood typing market?
Why is automation transforming operational efficiency in blood typing laboratories?
Why do Reagents & Consumables lead the blood typing market?
What is driving Organ Transplants as the fastest-growing application in blood typing?
Why does North America lead the blood typing market?
What is supporting blood typing market expansion in Asia Pacific?
What are the prominent companies operating in the blood typing landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization